[CTXR] YoY Annual Result on 30-Sep-2019 [#FY]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
16-Dec-2019
Financial Year
2019
Quarter
30-Sep-2019 [#FY]
Profit Trend
YoY- -24.26%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Annual Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -33,065 -23,054 -17,548 -15,562 -12,537 -10,385 -8,296 25.90%
Tax 576 71 126 16 1,284 851 9 99.93%
NP -33,641 -23,125 -17,674 -15,579 -12,537 -10,385 -8,296 26.26%
Tax Rate - - - - - - - -
Total Cost 33,641 23,125 17,674 15,579 12,537 10,385 8,296 26.26%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.23 -0.21 -0.45 -0.77 -1.17 -1.89 -2.29 -31.80%
EPS Diluted -0.23 -0.21 -0.45 -0.77 -1.17 -1.89 -2.29 -31.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.